| HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression … RK Gupta, J Gregson, N Parkin, H Haile-Selassie, A Tanuri, LA Forero, ... The Lancet infectious diseases 18 (3), 346-355, 2018 | 425 | 2018 |
| Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, I Fleminger, S Kirtley, ... The Lancet infectious diseases 19 (2), 143-155, 2019 | 352 | 2019 |
| Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study J Gregson, M Tang, N Ndembi, RL Hamers, SY Rhee, VC Marconi, ... The Lancet infectious diseases 16 (5), 565-575, 2016 | 287 | 2016 |
| Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ... PLoS medicine 12 (4), e1001810, 2015 | 282 | 2015 |
| Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004 V Pillay, J Ledwaba, G Hunt, M Rakgotho, B Singh, L Makubalo, ... Antiviral therapy 13 (2_suppl), 101-107, 2008 | 122 | 2008 |
| Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor–based therapy A Coovadia, G Hunt, EJ Abrams, G Sherman, T Meyers, G Barry, E Malan, ... Clinical infectious diseases 48 (4), 462-472, 2009 | 101 | 2009 |
| Evolution and diversity of HIV-1 in Africa–a review MA Papathanasopoulos, GM Hunt, CT Tiemessen Virus genes 26, 151-163, 2003 | 100 | 2003 |
| Reuse of nevirapine in exposed HIV-infected children after protease inhibitor–based viral suppression: a randomized controlled trial A Coovadia, EJ Abrams, R Stehlau, T Meyers, L Martens, G Sherman, ... Jama 304 (10), 1082-1090, 2010 | 96 | 2010 |
| Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis L Kuhn, G Hunt, KG Technau, A Coovadia, J Ledwaba, S Pickerill, ... Aids 28 (11), 1673-1678, 2014 | 92 | 2014 |
| Trends in pretreatment HIV-1 drug resistance in antiretroviral therapy-naive adults in South Africa, 2000–2016: a pooled sequence analysis B Chimukangara, RJ Lessells, SY Rhee, J Giandhari, ABM Kharsany, ... EClinicalMedicine 9, 26-34, 2019 | 73 | 2019 |
| Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, S Kirtley, ... The Lancet HIV 7 (11), e772-e781, 2020 | 70 | 2020 |
| Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys E Andersson, W Shao, I Bontell, F Cham, A Wondwossen, L Morris, ... Infection, Genetics and Evolution 18, 125-131, 2013 | 69 | 2013 |
| Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan … J Gregson, P Kaleebu, VC Marconi, C van Vuuren, N Ndembi, RL Hamers, ... The Lancet infectious diseases 17 (3), 296-304, 2017 | 66 | 2017 |
| Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a … L Kuhn, A Coovadia, R Strehlau, L Martens, CC Hu, T Meyers, G Sherman, ... The Lancet infectious diseases 12 (7), 521-530, 2012 | 65 | 2012 |
| Surveillance of transmitted HIV-1 drug resistance in Gauteng and KwaZulu-Natal provinces, South Africa, 2005–2009 GM Hunt, J Ledwaba, AE Basson, J Moyes, C Cohen, B Singh, ... Clinical infectious diseases 54 (suppl_4), S334-S338, 2012 | 57 | 2012 |
| HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine GM Hunt, A Coovadia, EJ Abrams, G Sherman, T Meyers, L Morris, ... Aids 25 (12), 1461-1469, 2011 | 57 | 2011 |
| Estimating the contribution of key populations towards HIV transmission in South Africa J Stone, C Mukandavire, MC Boily, H Fraser, S Mishra, S Schwartz, A Rao, ... African Journal of Reproduction and Gynaecological Endoscopy 24 (1), e25650, 2021 | 52 | 2021 |
| Human immunodeficiency virus (HIV) drug resistance in African infants and young children newly diagnosed with HIV: a multicountry analysis MR Jordan, M Penazzato, A Cournil, A Vubil, I Jani, G Hunt, S Carmona, ... Clinical Infectious Diseases 65 (12), 2018-2025, 2017 | 51 | 2017 |
| Low-abundance drug-resistant HIV-1 variants in antiretroviral drug-naive individuals: a systematic review of detection methods, prevalence, and clinical impact HA Mbunkah, S Bertagnolio, RL Hamers, G Hunt, S Inzaule, ... The Journal of infectious diseases 221 (10), 1584-1597, 2020 | 49 | 2020 |
| Efavirenz-based antiretroviral therapy among nevirapine-exposed HIV-infected children in South Africa: a randomized clinical trial A Coovadia, EJ Abrams, R Strehlau, S Shiau, F Pinillos, L Martens, ... Jama 314 (17), 1808-1817, 2015 | 47 | 2015 |
